SCINAI IMMUNOTHERAPEUTICS Trademark

Trademark Overview


On Tuesday, August 22, 2023, a trademark application was filed for SCINAI IMMUNOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SCINAI IMMUNOTHERAPEUTICS trademark a serial number of 79387398. The federal status of this trademark filing is REGISTERED as of Tuesday, November 12, 2024. This trademark is owned by BiondVax Pharmaceuticals Ltd.. The SCINAI IMMUNOTHERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations comprising antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases; Pharmaceutical preparations comprising immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases
scinai immunotherapeutics

General Information


Serial Number79387398
Word MarkSCINAI IMMUNOTHERAPEUTICS
Filing DateTuesday, August 22, 2023
Status700 - REGISTERED
Status DateTuesday, November 12, 2024
Registration Number7561660
Registration DateTuesday, November 12, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations comprising antigen-binding polypeptides for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases; Pharmaceutical preparations comprising immunoglobulin moieties, fragments or derivatives thereof for prevention and treatment of infectious diseases, immune and inflammatory diseases, malignancies and cancers, metabolic diseases, cardiovascular diseases, diseases of the central nervous system, and neurodegenerative diseases
Pseudo MarkSCINAI IMMUNO THERAPEUTICS
NOT AVAILABLE"IMMUNOTHERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 12, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameScinai Immunotherapeutics Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIL

Party NameScinai Immunotherapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIL

Party NameScinai Immunotherapeutics Ltd.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressIL

Party NameBiondVax Pharmaceuticals Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIL

Trademark Events


Event DateEvent Description
Tuesday, April 23, 2024NON-FINAL ACTION WRITTEN
Thursday, January 11, 2024SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, January 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 16, 2024APPLICATION FILING RECEIPT MAILED
Tuesday, April 23, 2024ASSIGNED TO EXAMINER
Wednesday, May 1, 2024REFUSAL PROCESSED BY MPU
Wednesday, May 1, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, May 22, 2024REFUSAL PROCESSED BY IB
Monday, July 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, July 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 9, 2024LETTER OF SUSPENSION E-MAILED
Tuesday, July 9, 2024SUSPENSION LETTER WRITTEN
Tuesday, July 9, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, July 18, 2024CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, July 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 23, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 12, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, November 12, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED